FILTERED RESULTS
FILTERS
Ads Top
DARK MODE
CHART
    Filters
      Symbols
      Sentiment
      Impact
      Search
      FILTERED RESULTS

        

      Upgrade your plan

      Eli Lilly Acquires Kelonia Therapeutics in $7 Billion Deal

      Eli Lilly announced on Monday its plan to acquire Kelonia Therapeutics for up to $7 billion. This strategic move aims to enhance Lilly's portfolio of cancer treatments.

      The acquisition of the privately held Kelonia Therapeutics is expected to bolster Eli Lilly's competitive position in the oncology market, where it will compete with major players such as Gilead and Johnson & Johnson.

      Lilly's investment reflects its commitment to expanding its capabilities in cancer care, as the company seeks to develop innovative therapies to address unmet medical needs in oncology.

      © 2026 KLEA News. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

      Source: KLEA News

      .

      Terra Founder Do Kwon Sentenced to 15 Years in Prison for Fraud